Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (24)
Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.
1993 • 2,828 citations
IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement.
1980 • 835 citations
Treatment of Established Renal Cancer by Tumor Cells Engineered to Secrete Interleukin-4
1991 • 733 citations
Human papillomavirus type 16 DNA sequence
1985 • 718 citations
The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells
1991 • 592 citations
Immunology: The ins and outs of antigen processing and presentations
1986 • 498 citations
Identification of two lysosomal membrane glycoproteins.
1985 • 475 citations
The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route
1990 • 445 citations
Follicular Dendritic Cells as Accessory Cells
1990 • 351 citations
Role for intracellular proteases in the processing and transport of class II HLA antigens.
1988 • 336 citations
Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells.
1985 • 295 citations
Glycoproteins of the lysosomal membrane.
1985 • 294 citations
Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene.
1994 • 287 citations
T and B memory cells
1994 • 285 citations
Accumulation of membrane glycoproteins in lysosomes requires a tyrosine residue at a particular position in the cytoplasmic tail.
1990 • 272 citations
The binary logic of antigen processing and presentation to T cells
1990 • 235 citations
In vivo priming of two distinct antitumor effector populations: the role of MHC class I expression.
1994 • 196 citations
The motif Tyr-X-X-hydrophobic residue mediates lysosomal membrane targeting of lysosome-associated membrane protein 1.
1993 • 169 citations
The NK-1.1(-) mouse: a model to study differentiation of murine NK cells.
1986 • 165 citations
Immunization against human papillomavirus type 16 tumor cells with recombinant vaccinia viruses expressing E6 and E7
1991 • 160 citations
Melanoma‐specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by epstein‐barr virus‐transformed B cells
1994 • 86 citations
Immunology of the human papilloma virus in relation to cancer
1994 • 77 citations
The effect of class II gene transfection on the tumourigenicity of the H-2K-negative mouse leukaemia cell line K36.16.
1991 • 46 citations
Rejection of K1735 murine melanoma in syngeneic hosts requires expression of MHC class I antigens and either class II antigens or IL-2.
1993 • 42 citations
Cited By (0)
No citing papers found in database